Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease
Clinical trial NCT05276570 · COMPLETED
Trial details
- NCT number
- NCT05276570
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2025-04-16
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.